NeuroOne Medical Technologies Corporation (NMTC)
USD 0.86
(0.0%)
USD 0.86
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 12.41 Million USD | 24.62% |
| 2022 | 9.95 Million USD | -1.59% |
| 2021 | 10.12 Million USD | 106.44% |
| 2020 | 4.9 Million USD | -15.67% |
| 2019 | 5.81 Million USD | 82.29% |
| 2018 | 3.18 Million USD | 3.8% |
| 2017 | 3.07 Million USD | 9321.12% |
| 2016 | 32.61 Thousand USD | 5.49% |
| 2015 | 30.91 Thousand USD | -15.73% |
| 2014 | 36.68 Thousand USD | 39.27% |
| 2013 | 26.34 Thousand USD | 79.76% |
| 2012 | 14.65 Thousand USD | -52.25% |
| 2011 | 30.68 Thousand USD | 325.57% |
| 2010 | 7211.00 USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 3.27 Million USD | -10.4% |
| 2024 Q3 | 3.07 Million USD | -6.13% |
| 2024 Q1 | 3.65 Million USD | 8.88% |
| 2023 Q2 | 3.52 Million USD | 99.06% |
| 2023 FY | 12.41 Million USD | 24.62% |
| 2023 Q4 | 3.35 Million USD | -10.54% |
| 2023 Q1 | 1.77 Million USD | 27.93% |
| 2023 Q3 | 3.75 Million USD | 6.42% |
| 2022 Q3 | 2.75 Million USD | -8.88% |
| 2022 FY | 9.95 Million USD | -1.59% |
| 2022 Q4 | 1.38 Million USD | -49.72% |
| 2022 Q2 | 3.02 Million USD | 8.13% |
| 2022 Q1 | 2.79 Million USD | 6.44% |
| 2021 Q4 | 2.62 Million USD | -12.82% |
| 2021 FY | 10.12 Million USD | 106.44% |
| 2021 Q1 | 2.1 Million USD | 3.02% |
| 2021 Q2 | 2.37 Million USD | 12.77% |
| 2021 Q3 | 3.01 Million USD | 26.89% |
| 2020 Q2 | 1.37 Million USD | -24.07% |
| 2020 Q1 | 1.81 Million USD | 34.02% |
| 2020 Q3 | 1.59 Million USD | 15.69% |
| 2020 FY | 4.9 Million USD | -15.67% |
| 2020 Q4 | 2.04 Million USD | 28.27% |
| 2019 Q1 | 1.07 Million USD | -52.17% |
| 2019 Q4 | 1.35 Million USD | -27.35% |
| 2019 Q3 | 1.86 Million USD | 22.47% |
| 2019 Q2 | 1.52 Million USD | 41.39% |
| 2019 FY | 5.81 Million USD | 82.29% |
| 2018 Q2 | 1.09 Million USD | 41.83% |
| 2018 Q4 | 2.24 Million USD | 91.9% |
| 2018 FY | 3.18 Million USD | 3.8% |
| 2018 Q3 | 1.17 Million USD | 6.81% |
| 2018 Q1 | 773.78 Thousand USD | -13.43% |
| 2017 FY | 3.07 Million USD | 9321.12% |
| 2017 Q4 | 893.79 Thousand USD | 0.57% |
| 2017 Q3 | 888.68 Thousand USD | 72.21% |
| 2017 Q2 | 516.05 Thousand USD | 182.51% |
| 2017 Q1 | 182.66 Thousand USD | 9310.97% |
| 2016 Q1 | 14.85 Thousand USD | 473.58% |
| 2016 Q2 | 4386.00 USD | -70.46% |
| 2016 Q4 | 1941.00 USD | -86.24% |
| 2016 Q3 | 14.1 Thousand USD | 221.66% |
| 2016 FY | 32.61 Thousand USD | 5.49% |
| 2015 FY | 30.91 Thousand USD | -15.73% |
| 2015 Q4 | 2589.00 USD | -86.13% |
| 2015 Q3 | 18.66 Thousand USD | 92.7% |
| 2015 Q2 | 9687.00 USD | -3.54% |
| 2015 Q1 | 10.04 Thousand USD | 60.46% |
| 2014 Q3 | 16.32 Thousand USD | 301.72% |
| 2014 Q2 | 4063.00 USD | 49.21% |
| 2014 Q1 | 2723.00 USD | -45.34% |
| 2014 FY | 36.68 Thousand USD | 39.27% |
| 2014 Q4 | 6259.00 USD | -61.65% |
| 2013 Q2 | 3391.00 USD | 96.35% |
| 2013 Q4 | 4982.00 USD | -67.32% |
| 2013 Q3 | 15.24 Thousand USD | 349.6% |
| 2013 FY | 26.34 Thousand USD | 79.76% |
| 2013 Q1 | 1727.00 USD | -63.67% |
| 2012 Q1 | 13.61 Thousand USD | 175.76% |
| 2012 Q3 | 2677.00 USD | -52.75% |
| 2012 Q4 | 4754.00 USD | 77.59% |
| 2012 FY | 14.65 Thousand USD | -52.25% |
| 2012 Q2 | 5666.00 USD | -58.39% |
| 2011 Q3 | 2400.00 USD | -75.34% |
| 2011 Q4 | 4938.00 USD | 105.75% |
| 2011 Q1 | 547.00 USD | -90.0% |
| 2011 Q2 | 9733.00 USD | 1679.34% |
| 2011 FY | 30.68 Thousand USD | 325.57% |
| 2010 Q3 | 3177.00 USD | 0.0% |
| 2010 FY | 7211.00 USD | 0.0% |
| 2010 Q4 | 5471.00 USD | 72.21% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -10.582% |
| Cerus Corporation | 143.15 Million USD | 91.33% |
| OrthoPediatrics Corp. | 137.01 Million USD | 90.942% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -9.25% |
| Talis Biomedical Corporation | 67.18 Million USD | 81.526% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 50.245% |
| Inogen, Inc. | 236.08 Million USD | 94.743% |
| Spectral AI, Inc. | 20.86 Million USD | 40.511% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 77.835% |
| CVRx, Inc. | 76.14 Million USD | 83.699% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -251.808% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | 0.618% |
| Orthofix Medical Inc. | 667.42 Million USD | 98.14% |
| Venus Concept Inc. | 80.47 Million USD | 84.577% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 78.063% |
| Bioventus Inc. | 409.91 Million USD | 96.972% |
| BrainsWay Ltd. | 28.01 Million USD | 55.701% |
| Envoy Medical, Inc. | 17.89 Million USD | 30.653% |
| electroCore, Inc. | 32.03 Million USD | 61.251% |
| IceCure Medical Ltd | 16.87 Million USD | 26.453% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 70.749% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 29.611% |
| MaxCyte, Inc. | 84.84 Million USD | 85.371% |
| Nexalin Technology, Inc. | 5.78 Million USD | -114.686% |
| PAVmed Inc | 64.82 Million USD | 80.854% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 75.7% |
| RxSight, Inc. | 103.85 Million USD | 88.048% |
| Sight Sciences, Inc. | 126.44 Million USD | 90.184% |
| SI-BONE, Inc. | 156.35 Million USD | 92.062% |
| TELA Bio, Inc. | 84.18 Million USD | 85.257% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 82.283% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 93.897% |
| LivaNova PLC | 843.54 Million USD | 98.529% |
| 908 Devices Inc. | 68.08 Million USD | 81.769% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 97.433% |
| Nemaura Medical Inc. | 7.13 Million USD | -73.863% |
| NeuroPace, Inc. | 75.29 Million USD | 83.516% |
| LENSAR, Inc. | 33.33 Million USD | 62.768% |
| Apyx Medical Corporation | 51.01 Million USD | 75.672% |
| Cutera, Inc. | 197.72 Million USD | 93.723% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 49.914% |
| BioSig Technologies, Inc. | 28.53 Million USD | 56.496% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 93.518% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 65.58% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 98.516% |
| Axonics, Inc. | 270.2 Million USD | 95.406% |
| Outset Medical, Inc. | 198.77 Million USD | 93.756% |
| IRIDEX Corporation | 31.81 Million USD | 60.986% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 93.113% |
| IRadimed Corporation | 30.12 Million USD | 58.796% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -45.473% |
| INVO Bioscience, Inc. | 7.85 Million USD | -58.045% |
| Telesis Bio, Inc. | 63.48 Million USD | 80.451% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 87.393% |
| Varex Imaging Corporation | 224.8 Million USD | 94.479% |
| Quipt Home Medical Corp. | 148.66 Million USD | 91.651% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -5.875% |
| Pulmonx Corporation | 112.68 Million USD | 88.986% |
| Dynatronics Corporation | 9.9 Million USD | -25.27% |
| Modular Medical, Inc. | 17.52 Million USD | 29.193% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 38.516% |
| Semler Scientific, Inc. | 38.94 Million USD | 68.129% |
| InMode Ltd. | 215.68 Million USD | 94.245% |
| Bruker Corporation | 1.07 Billion USD | 98.847% |
| Cytosorbents Corporation | 48.33 Million USD | 74.322% |
| DexCom, Inc. | 1.69 Billion USD | 99.266% |
| Align Technology, Inc. | 2.07 Billion USD | 99.402% |
| Viveve Medical, Inc. | 22.17 Million USD | 44.023% |
| ZimVie Inc. | 275.12 Million USD | 95.489% |
| Movano Inc. | 29.69 Million USD | 58.195% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 90.958% |
| Nexalin Technology, Inc. | 5.78 Million USD | -114.686% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -251.808% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 97.935% |
| Profound Medical Corp. | 33.6 Million USD | 63.064% |
| Insulet Corporation | 939.9 Million USD | 98.679% |
| enVVeno Medical Corporation | 25.23 Million USD | 50.821% |
| Surmodics, Inc. | 98.69 Million USD | 87.424% |
| iCAD, Inc. | 22.22 Million USD | 44.154% |
| Nuwellis, Inc. | 22.61 Million USD | 45.112% |
| Biotricity, Inc. | 17.18 Million USD | 27.774% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 97.216% |
| Aethlon Medical, Inc. | 12.27 Million USD | -1.094% |
| InspireMD, Inc. | 22.95 Million USD | 45.918% |
| PAVmed Inc. | 64.82 Million USD | 80.854% |
| BIOLASE, Inc. | 34.66 Million USD | 64.191% |
| Beyond Air, Inc. | 61.7 Million USD | 79.884% |
| FONAR Corporation | 28.6 Million USD | 56.609% |
| AxoGen, Inc. | 149.33 Million USD | 91.689% |
| Vivani Medical, Inc. | 26.96 Million USD | 53.971% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 92.991% |
| Inari Medical, Inc. | 448.59 Million USD | 97.233% |
| UFP Technologies, Inc. | 58.08 Million USD | 78.633% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -151.883% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -96.442% |
| Tenon Medical, Inc. | 16.96 Million USD | 26.852% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -67.885% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 71.857% |
| AdaptHealth Corp. | 1.07 Billion USD | 98.849% |
| Sintx Technologies, Inc. | 15.2 Million USD | 18.349% |
| NanoVibronix, Inc. | 4.97 Million USD | -149.583% |
| Quanterix Corporation | 118.1 Million USD | 89.49% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -5.875% |
| Sensus Healthcare, Inc. | 14.44 Million USD | 14.058% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 96.839% |
| TransMedics Group, Inc. | 182.82 Million USD | 93.211% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 55.775% |
| NeuroMetrix, Inc. | 11.09 Million USD | -11.828% |
| Hyperfine, Inc. | 52.87 Million USD | 76.525% |
| Establishment Labs Holdings Inc. | 172 Million USD | 92.784% |
| Biomerica, Inc. | 6.97 Million USD | -77.87% |
| Bone Biologics Corporation | 9.42 Million USD | -31.644% |
| AVITA Medical, Inc. | 80.77 Million USD | 84.635% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -20.372% |
| Silk Road Medical, Inc | 186.35 Million USD | 93.34% |